|
|
Title | Creator | Date |
1 |
|
A Randomized Prospective Trial Comparing Repository Corticotropin Injection and Intravenous Methylprednisolone for Neuroprotection in Acute Optic Neuritis | Jeffrey L. Bennett; Nathan C. Grove; Ruth K. Johnson; Christopher Mizenko; Joan C. DuPont; Brandie D. Wagner; Anne M. Lynch; Teresa C. Frohman; Kenneth S. Shindler; Elliot M. Frohman | 2023-09 |
2 |
|
Sharp Edge Eye Syndrome: A Case Report and Survey of Self-Identified Individuals | Merrick S. Reynolds; Bradley J. Katz; Kathleen B. Digre; Ben J. Brintz; Lenora M. Olson; Judith E. A. Warner | 2022-12 |
3 |
|
The Impact of Leber Hereditary Optic Neuropathy on the Quality of Life of Patients and Their Relatives: A Qualitative Study | Benson S. Chen; Erik Holzinger; Magali Taiel; Patrick Yu-Wai-Man | 2022-09 |
4 |
|
An Exploratory Study to Investigate the Utility of Clinical Screening for Neurodegenerative Disease in Age-Related Eye Disease Research | Victoria S. Pelak; Yosbelkys Martin Paez; Jennifer L. Patnaik; Samantha K. Holden; Prem S. Subramanian; Marc T. Mathias; Naresh Mandava; Anne M. Lynch | 2022-09 |
5 |
|
Expert Consensus on the Use of Teprotumumab for the Management of Thyroid Eye Disease Using a Modified-Delphi Approach | Raymond S. Douglas; Andrea L. Kossler; Jody Abrams; Cesar A. Briceño; David Gay; Andrew Harrison; Michael Lee; John Nguyen; Shannon S. Joseph; Dianne Schlachter; Jeremy Tan; Judah Lynch; Louisa Oliver; Richard Perry; Shoaib Ugradar | 2022-09 |
6 |
|
Impact of Greater Occipital Nerve Block on Photophobia Levels in Migraine Patients | Javier A Membrilla; Íñigo de Lorenzo; Lucía Sánchez-Casado; María Sastre; Javier Díaz de Terán | 2022-09 |
7 |
|
Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study | Valérie Biousse; Nancy J Newman; Patrick Yu-Wai-Man; Valerio Carelli; Mark L Moster; Catherine Vignal-Clermont; Thomas Klopstock; Alfredo A Sadun; Robert C Sergott; Rabih Hage; Simona Esposti; Chiara La Morgia; Claudia Priglinger; Rustum Karanja; Laure Blouin; Magali Taiel; José-Alain Sahel; LHON ... | 2021-09 |
8 |
|
Acute Care and Treatment of Migraine | Spingos Konstantinos, MD, PgD; Michail Vikelis, MD, MSc, PhD; Alan Rapoport, MD | 2020-12 |
9 |
|
Gabapentin and Memantine for Treatment of Acquired Pendular Nystagmus: Effects on Visual Outcomes | Elodie Nerrant; Lucie Abouaf; Frédéric Pollet-Villard; Anne-Laure Vie; Sandra Vukusic; Julien Berthiller; Bettina Colombet; Alain Vighetto; Caroline Tilikete | 2020-06 |
10 |
|
Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab | Jennifer Petrillo; Laura Balcer; Steven Galetta; Yi Chai; Lei Xu; Diego Cadavid | 2019-06 |
11 |
|
Neurological and Ophthalmological Manifestations of Varicella Zoster Virus | Sachin Kedar; Lakshman N. Jayagopal; Joseph R. Berger | 2019-06 |
12 |
|
Evaluation of Vision-Related Quality of Life in Chinese Patients With Leber Hereditary Optic Neuropathy and the G11778A Mutation. | Shilei Cui; MD; Hanqiu Jiang; MD; PhD; Jingting Peng; MD; PhD;Jiawei Wang; MD; PhD; Xiaojun Zhang; MD; PhD | 2019-03 |
13 |
|
Rehabilitation of Visual Loss: Where We Are and Where We Need to Be | Behzad Mansouri, MD, PhD, FRCPC; Marinya Roznik, Bsc; Joseph F. Rizzo III, MD; Sashank Prasad, MD | 2018-06 |
14 |
|
More Than Meets the Eye: The Eye and Migraine -- What You Need to Know | Kathleen B. Digre, MD | 2018-06 |
15 |
|
Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial | Martin W. ten Hove, MD; Deborah I. Friedman, MD; Anil D. Patel, MD; Isabella Irrcher, PhD; Michael Wall, MD; Michael P. McDermott, PhD; for the NORDIC Idiopathic Intracranial Hypertension Study Group | 2016-03 |
16 |
|
Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial | Kimberly E. Cello, BS; John L. Keltner, MD; Chris A. Johnson, PhD; Michael Wall, MD for the NORDIC Idiopathic Intracranial Hypertension Study Group | 2016-03 |
17 |
|
Correlation of Visual Quality of Life With Clinical and Visual Status in Friedreich Ataxia | | |